logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
相

相小强 (Xiaoqiang Xiang)

fudan university

31H指数
160论文数
3.4K被引数
收录论文 75
发表时间
logo
PBPK Modeling of Coproporphyrin I Reveals Frailty-Associated Changes in Hepatic OATP1B1 Function in Chinese AdultsPBPK模型对粪卟啉I的建模揭示了中国成年人肝OATP1B1功能与脆弱性相关的变化
errClinical Pharmacokinetics
IF4
err2026-09-21
err0
PREAI
errLongjie Li; Mengfan Ye; Wenhang Xu; Xinyan Zhu; Like Xie; Haiping Xu; Qingfeng He; Xiao Zhu; Xiaoqiang Xiang; Juan Xie
err分享
err收藏
Translational pharmacokinetic/pharmacodynamic modeling to inform target concentration and dose projection of a novel selective estrogen receptor degrader (SIM0270) for early clinical development新型选择性雌激素受体降解剂（SIM0270）早期临床开发中靶浓度和剂量预测的翻译药代动力学/药效动力学建模
errJournal of Pharmacology and Experimental Therapeutics
IF3.8
err2026-09-02
err0
PREAI
errYufei Shi; Meng Gu; Yang Yang; Shansen Xu; Qingfeng He; Peijin Li; Qi Fu; Chen Yang; Xiaoqiang Xiang; Jia Chen; Xiao Zhu
err分享
err收藏
Dose optimization of sacubitril/valsartan in Chinese chronic heart failure patients: integration of physiologically based pharmacokinetic modeling and real-world data沙库巴曲/缬沙坦在中国慢性心力衰竭患者中的剂量优化：生理药代动力学模型与真实世界数据的整合
errFrontiers in Pharmacology
IF4.8
err2026-08-14
err0
errOAAI
errKR Ke Ren †; MF Ming Fan †; MJ Mengqi Jia; ZW Zi Wang; XZ Xiao Zhu; BH Bing Han; XX Xiaoqiang Xiang; YZ Yanxia Zhang; QH Qingfeng He
err分享
err收藏
Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations生理药代动力学模型在多种临床人群中的开发与评价：关于Cipepofol
errPharmaceutics
IF5.5
err2026-07-28
err0
errOAAI
errJunmin Li; Longjie Li; Fangbin Ding; Meixia Chen; Mengyue Hu; Xiaoqiang Xiang; Jing Tang
err分享
err收藏
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions开发一种用于预测UGT1A1/CYP3A介导的药物-药物相互作用的伊立替康及其代谢物的成年全身生理药代动力学模型
errFrontiers in Pharmacology
IF4.8
err2026-05-27
err0
errOAAI
errBC Bowen Chen †; LL Longjie Li †; WX Wenhang Xu; HX Haiping Xu; XZ Xinyan Zhu; QH Qingfeng He; XZ Xiao Zhu; PC Paul Chi-Lui Ho; XX Xiaoqiang Xiang; PJ Peiying Ji
err分享
err收藏
Guiding a Diclofenac Sodium Dual-Release Sustained Formulation Development Through In Vitro–In Vivo Relationship Based on Physiologically Based Pharmacokinetics基于生理药代动力学，通过体内外关系指导双氯芬酸钠双释缓释制剂的开发
errPharmaceutics
IF5.5
err2026-05-18
err0
errOAAI
errQizheng Wang; Pengcheng Guo; Tianci Hu; Longjie Li; Tingxi Zhu; Yue Pan; Xiaoqiang Xiang; Jianxin Wang
err分享
err收藏
Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator基于生理药代动力学建模预测氟马替尼作为受害者与致因药物时介导的CYP3A4药物-药物相互作用机理
errdrug design; development and therapy
IF0
err2026-05-09
err0
errOAAI
errMuyesaier Alifu; Xue Chu; Xinyan Zhu; Wen Yao Mak; Aole Zheng; Chunyang Pan; Qingfeng He; Xiao Zhu; Zheng Kuai; Xiaoqiang Xiang
err分享
err收藏
Population Pharmacokinetics of Sacubitril/Valsartan in Patients with Heart Failure and End-Stage Renal Disease Undergoing Peritoneal Dialysis沙库巴曲缬沙坦在伴有心力衰竭和终末期肾病并进行腹膜透析患者中的群体药代动力学
errClinical Pharmacokinetics
IF4
err2026-04-29
err0
PREAI
errYing Jin; Nuo Xu; Wenyu Yang; Bijue Liu; Runhan Liu; Yufei Shi; Mengyu Zhang; Xiaoqiang Xiang; Zhenlei Wang; Xiao Zhu
err分享
err收藏
A rapid, economical, and eco-friendly matrix solid-phase dispersion extraction–dual-wavelength ultraviolet (MSPD–DUV) method for quality evaluation of Magnolia Officinalis Cortex (Houpo)快速、经济且环保的基质固相分散提取-双波长紫外（MSPD–DUV）法用于厚朴质量评价
errMicrochemical Journal
IF5.1
err2026-04-16
err0
PREAI
errXiaoqiang Xiang; Wenhao Wang; Zhinan Mei; Haiyan Tian; Weiqi Yang; Dan Tang; Zhengming Qian
err分享
err收藏
Lithocarpus litseifolius and trilobatin ameliorate diabetic nephropathy through alleviating carbonyl stress by inhibiting AGEs/RAGE/NF-κB pathway石栎叶青冈和三叶因子通过抑制AGEs/RAGE/NF-κB通路缓解糖基化应激，改善糖尿病肾病
errPhytomedicine
IF8.3
err2026-04-15
err0
PREAI
errXue-Min Chen; Jie-Xin Chen; Xiao-Mei Chen; Yu-Xin Gao; Chen-Yue Zeng; Die-Yi Chen; Xiao-Qiang Xiang; Xiao-Tong Hao; Shu-Mei Wang; Dan Tang
err分享
err收藏
Population Time-to-Event Modeling of Pregnancy Loss Risk Following Frozen Embryo Transfer: A Real-World Study in Chinese Women
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2025-12-01
err0
PREAI
errMak, Wen Yao; Alifu, Muyesaier; Zheng, Aole; Jia, Ning; He, Qingfeng; Zhu, Xiao; Mao, Xiaoyan; Xiang, Xiaoqiang
err分享
err收藏
Model-Informed Evidence for Rifapentine Use in Chinese HIV-Positive Adults with Latent Tuberculosis: Assessing Ethnic PK Differences and Interactions with Ritonavir基于模型证据探讨利福喷丁在中国HIV阳性潜伏结核患者中的应用：评估种族药代动力学差异及与利托那韦的相互作用
errInternational Journal of Infectious Diseases
IF4.3
err2025-11-15
err0
errOAAI
errHongyi Yang; Weijian Liu; Nuo Xu; Wei Li; Wen Yao Mak; Chaozhuang Shen; Liang Zheng; Qingfeng He; Yehua Xie; Xiaoqiang Xiang; Peize Zhang; Xiao Zhu
err分享
err收藏
Optimizing Linezolid Dosing for Nosocomial Urinary Tract Infections in Critically Ill Patients with Renal Impairment优化肾功能障碍重症患者医院获得性尿路感染的利奈唑胺给药剂量
errInternational Journal of Antimicrobial Agents
IF4.6
err2025-09-05
err0
PREAI
errAdela Benítez-Cano; Xin Liu; Haiping Xu; Xinyi Tang; Luigi Zattera; Daniel Fresan; Luisa Sorlí; Jesús Carazo; Isabel Ramos; Ramón Adalia; Juan Pablo Horcajada; Nuo Xu; Wenyao Mak; Xiaoqiang Xiang; Julia Miedes-Aliaga; Cristina Bosch; Elena Colominas-González; Sonia Luque; Xiao Zhu
err分享
err收藏
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors基于终末期肾病患者的PBPK群体模型开发，以阐明受OATP1B-、BCRP-、P-gp-和CYP3A4介导的药物处置及个体影响因素
errPharmaceutics 2025, Vol. 17, Page 1078
IF5.5
err2025-08-20
err0
PREAI
errYujie Wu; Weijie Kong; Jiayu Li; Xiaoqiang Xiang; Hao Liang; Dongyang Liu
err分享
err收藏
Physiologically-Based Pharmacokinetics and Empirical Pharmacodynamic Modeling for Pediatric Henagliflozin Dosing: Clinical Insights for Chinese Patients基于生理的药代动力学和经验性药效动力学建模在儿科亨格利氟森给药中的应用：中国患者的临床见解
errPediatric Diabetes
IF5.6
err2025-08-08
err0
errOAAI
errXinyue Zhang; Hao Xue; Jialei Xu; Ke Ren; Fangyi Qian; Yifan Zhang; Jingru Dou; Kai Shen; Xiao Zhu; Xiaoqiang Xiang; Qingfeng He
err分享
err收藏
Cost–utility analysis of sotagliflozin for heart failure patients with diabetes in China中国糖尿病患者心力衰竭患者 sotagliflozin 的成本-效用分析
errBritish Journal of Clinical Pharmacology
IF3
err2025-08-02
err0
PREAI
errXinyue Zhang; Fangyi Qian; Zhen Feng; Yunrong Shen; Nan Guo; Zhijia Tang; Aole Zheng; Xiao Zhu; Xiaoqiang Xiang; Qingfeng He
err分享
err收藏
Physiologically-based pharmacokinetic modeling of rosuvastatin in Chinese: Predicting the impact of SLCO1B1 and ABCG2 genetic variants and hepatic impairment on drug exposure基于生理学的罗苏伐他汀药代动力学建模研究：预测SLCO1B1和ABCG2基因变异以及肝功能不全对药物暴露的影响
errJournal of Pharmaceutical Sciences
IF3.8
err2025-06-07
err0
PREAI
errLongjie Li; Xinyan Zhu; Wenhang Xu; Qingfeng He; Like Xie; Haishu Lin; Mengfan Ye; Paul Chi-Lui Ho; Juan Xie; Xiaoqiang Xiang
err分享
err收藏
Corrigendum to “Rat-to-human PBPK model of U-47700: Unveiling pharmacokinetic risks of a synthetic opioid through interspecies extrapolation” [Toxicology and Applied Pharmacology, 499 (2025) 117352]勘误：U-47700的种属间外推大鼠-人PBPK模型：通过种属间外推揭示合成阿片类药物的药代动力学风险 [毒理学与治疗药理学，499（2025）117352]
errToxicology and Applied Pharmacology
IF3.4
err2025-06-04
err0
PREAI
errLina Zhong; Longjie Li; Qingfeng He; Xiao Zhu; Ping Xiang; Xiaoqiang Xiang; Hui Yan
err分享
err收藏
Correction: Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling修正：使用生理药代动力学模型为卡马西平片剂建立临床相关的规格要求
erraaps journal
IF0
err2025-06-04
err0
PREAI
errXiaofeng Wang; Longjie Li; Hongyi Yang; Qingfeng He; Xiao Zhu; Jiajing Wang; Bo Sun; Peng Liu; Xiaoqiang Xiang
err分享
err收藏
Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipients利奈唑胺在肝移植受者中的群体药代动力学和血小板减少症风险评估
errJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
err2025-05-13
err0
PREAI
errShi, Xiaoping; Yang, Wenyu; Zhao, Fanyu; Lao, Donghui; Xu, Qing; Li, Xiaoyu; Lv, Qianzhou; He, Qingfeng; Xiang, Xiaoqiang; Wang, Ting
err分享
err收藏

研究方向

定量药理学药物基因组学
合作学者
合作期刊
G
Gautam Sethi
H 指数: 136 · 论文数: 840
H
H. Phillip Koeffler
H 指数: 122 · 论文数: 1.1K
王
王倩 (Qian Wang)
H 指数: 101 · 论文数: 2.2K
A
Alan Prem Kumar
H 指数: 94 · 论文数: 370
乔
乔杰 (Jie Qiao)
H 指数: 93 · 论文数: 1.1K
查看更多